Ghost Tree Capital as of June 30, 2014
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 54 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr option | 10.3 | $15M | 75k | 195.72 | |
| Mylan Inc Cmn Stock cmn | 5.5 | $7.7M | 150k | 51.56 | |
| Actavis | 4.7 | $6.7M | 30k | 223.07 | |
| Medivation | 4.3 | $6.2M | 80k | 77.08 | |
| Cooper Companies | 3.8 | $5.4M | 40k | 135.52 | |
| Teva Pharmaceutical Industries (TEVA) | 3.7 | $5.2M | 100k | 52.42 | |
| Boston Scientific Corporation (BSX) | 3.6 | $5.1M | 400k | 12.77 | |
| Medtronic | 3.4 | $4.8M | 75k | 63.76 | |
| Alnylam Pharmaceuticals (ALNY) | 3.3 | $4.7M | 75k | 63.17 | |
| Community Health Systems (CYH) | 3.2 | $4.5M | 100k | 45.37 | |
| AtriCure (ATRC) | 2.9 | $4.1M | 225k | 18.38 | |
| Insmed (INSM) | 2.8 | $4.0M | 200k | 19.98 | |
| Biodelivery Sciences Intl In | 2.5 | $3.6M | 300k | 12.07 | |
| Spectranetics Corporation | 2.3 | $3.3M | 143k | 22.88 | |
| Bruker Corporation (BRKR) | 2.2 | $3.2M | 130k | 24.27 | |
| Synageva Biopharma | 2.2 | $3.1M | 30k | 104.80 | |
| Tornier Nv | 2.0 | $2.8M | 120k | 23.38 | |
| Covidien | 1.9 | $2.7M | 30k | 90.17 | |
| Anacor Pharmaceuticals In | 1.9 | $2.7M | 150k | 17.73 | |
| Hca Holdings (HCA) | 1.8 | $2.5M | 45k | 56.38 | |
| Intercept Pharmaceuticals In | 1.7 | $2.4M | 10k | 236.60 | |
| Prosensa Hldgs B V Shs Usd | 1.6 | $2.2M | 175k | 12.62 | |
| Accuray Incorporated (ARAY) | 1.6 | $2.2M | 250k | 8.80 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $2.2M | 50k | 43.08 | |
| Gw Pharmaceuticals Plc ads | 1.5 | $2.1M | 20k | 107.30 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $2.1M | 7.5k | 282.53 | |
| AMAG Pharmaceuticals | 1.5 | $2.1M | 100k | 20.72 | |
| Amicus Therapeutics (FOLD) | 1.4 | $2.0M | 600k | 3.34 | |
| Smith & Nephew (SNN) | 1.3 | $1.8M | 20k | 89.30 | |
| Edwards Lifesciences (EW) | 1.2 | $1.7M | 20k | 85.85 | |
| DepoMed | 1.2 | $1.7M | 120k | 13.90 | |
| Depomed Inc Cmn Stock cmn | 1.2 | $1.7M | 120k | 13.90 | |
| Nps Pharmaceuticals Inc Cmn Stock cmn | 1.2 | $1.7M | 50k | 33.06 | |
| Orexigen Therapeutics | 1.1 | $1.5M | 250k | 6.18 | |
| Receptos | 1.1 | $1.5M | 35k | 42.60 | |
| NPS Pharmaceuticals | 0.9 | $1.3M | 40k | 33.05 | |
| Achillion Pharmaceuticals In cmn | 0.8 | $1.1M | 150k | 7.57 | |
| Flamel Technologies | 0.8 | $1.1M | 75k | 15.00 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.8 | $1.1M | 437k | 2.53 | |
| Therapeuticsmd | 0.8 | $1.1M | 250k | 4.42 | |
| Inovio Pharmaceuticals Inc cmn | 0.8 | $1.1M | 100k | 10.81 | |
| Cynosure | 0.8 | $1.1M | 50k | 21.26 | |
| Nanostring Technologies (NSTGQ) | 0.7 | $1.0M | 70k | 14.96 | |
| Air Methods Corporation | 0.7 | $1.0M | 20k | 51.65 | |
| Infinity Pharmaceuticals (INFIQ) | 0.7 | $956k | 75k | 12.75 | |
| Unilife US | 0.6 | $888k | 300k | 2.96 | |
| Heron Therapeutics (HRTX) | 0.6 | $862k | 70k | 12.31 | |
| Ocera Therapeutics | 0.5 | $764k | 100k | 7.64 | |
| Revance Therapeutics (RVNC) | 0.5 | $680k | 20k | 34.00 | |
| Biolase Technology | 0.5 | $660k | 300k | 2.20 | |
| Dyax | 0.4 | $624k | 65k | 9.60 | |
| INC Ventrus Biosciences | 0.2 | $262k | 200k | 1.31 | |
| Wright Med Group Inc right 03/01/2019 | 0.1 | $82k | 55k | 1.49 | |
| Puma Biotechnology (PBYI) | 0.1 | $66k | 1.0k | 66.00 |
